The Cardano Foundation has published its 2025 financial statements on the blockchain, accompanied by an independent auditor's attestation from Grant Thornton. This is the first time the Foundation has combined traditional audit verification with on-chain reporting, aiming to increase transparency and trust in its financial health. As a Swiss nonprofit supporting the Cardano blockchain, this move may reduce perceived financial risks and encourage other organizations to adopt similar blockchain-based transparency measures. Market watchers will see if this trend influences confidence and stability perceptions in the broader tech and crypto sectors.
The Cardano Foundation's move to put its 2025 financials on-chain comes as a backdrop to the broader crypto market where 30 out of 50 major cryptocurrencies rose today. Among these, Algorand (ALGO) traded at Rp1.771 with a 1-day change of +4.05%, showing a Pluang order activity split of 66% Sell and 34% Buy. This snapshot is as of Nov 04, 2026 21:23 WIB, with other notable movers including Nano (XNO) at Rp5.954 and Curve DAO Token (CRV) at Rp4.904, both up by over 3%.
Goldman Sachs Group, Inc. disclosed that it briefly held a combined stake exceeding 3% in Ontex Group NV shares as of October 27, 2026, with 566,115 voting rights and 1,965,157 financial instruments. However, by October 28, 2026, their combined posit...
BNP Paribas announced its monthly declaration of voting rights and shares as of October 31, 2026. The bank reported a total of 1,101,600,607 shares and an equal number of voting rights. This update is part of regulatory compliance under French commer...
Ontex disclosed that Goldman Sachs Group, Inc. crossed the 3% ownership threshold in Ontex shares on October 27, 2026, holding a combined total of 3.07% including voting rights and financial instruments. However, the next day, October 28, 2026, Goldm...
Neion Bio has appointed John A. Maga, Ph.D., as Head of Biologics and CMC to lead the development of biologic medicines using its Raptor platform, which produces proteins in transgenic chicken eggs. Maga brings over 25 years of biopharmaceutical expe...
The National Advertising Division (NAD) recommended that Good Life Meds discontinue claims about health benefits and personalization for its compounded Tirzepatide+ weight loss products after a challenge by Eli Lilly. NAD found that Good Life lacked ...
